Patients don't respond to Ebola medicine, world seeks new direction even in the dark

BanglaHunt Desk: America gave a new news in the growing Corona (COVID-19) attack. It is possible to be able to deal with the corona virus with the application of Rendesiv, said the US Pharma Agency. The success of the Ebola drug has been matched by success, and the number of healthy people has increased.

Tests have shown that the use of the Ebola vaccine has prevented the spread of the deadly virus in the body of an infected person. The drug will be approved by the FDA. As a result, the world has seen a glimmer of hope.

In this context, Dr. Abhijit Chowdhury said, ‘We are all waiting for a moment like this where we can come up with a pharmacological solution for the treatment of people with corona. We are very pleased that the US Agency for International Development (USAID) is applying this drug and that Corona is recovering quickly. However, it is still under study. But when we see a flash of lightning in the darkness, we look forward to it. In this case too, we are going through such a period. At first we didn't have the right tools to fight the corona virus. However, if the application of this drug can really prevent the spread of this disease, then it is a blessing for all.

He added, ‘But keep in mind that this is a phase three trial. And there are indications that as soon as possible the next morning the US Federal Drug Administration is going to recognize this drug. This drug was seen to be applied in severely infected individuals. However, Dr. Fausio said that even if the drug is not 100 percent successful, the effort must be continued. But when science discovers a cure for a disease, they go step by step. Many times not one drug, many drugs can prevent any deadly disease. So you have to be a little patient with this medicine too. '

Although the US agency has approved the drug, he said it was being used in India and Bengal. With which the treatment of about 1 lakh 40 thousand people is possible now. However, there are many pharmaceutical companies in India that can make a lot of medicines in a very short time and at a very low cost. So we will be relying on the scientists of Indian Pharmaceutical Science. And I hope that as soon as the government agrees with them, they will be able to make this antidote quickly. '